A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
On the Lookout: The Software Supply Chain as a Healthcare Cyberattack Vector
Hackensack Meridian Health & Wellness Center at Clifton Opens
Suffolk Breaks Ground on Expansion of White Plains Hospital
EVS Leadership Culture Critical in Preventing Hospital-Acquired Sepsis
Man Dies by Suicide in Emergency Department Waiting Room at Kansas Hospital